Product Name: AP3B2 Antibody
Species Reactivity: Human, Mouse, Rat
Tested Applications: ELISA, IF, IHC-P, WB
Applications: AP3B2 antibody can be used for detection of AP3B2 by Western blot at 1 – 2 μg/mL. Antibody can also be used for immunohistochemistry starting at 5 μg/mL. For immunofluorescence start at 20 μg/mL.
User Note: Optimal dilutions for each application to be determined by the researcher.
Predicted Molecular Weight: Predicted: 121 kDa Observed: 128 kDa
Immunogen: AP3B2 antibody was raised against an 18 amino acid synthetic peptide near the amino terminus of human AP3B2.The immunogen is located within the first 50 amino acids of AP3B2.
Host Species: Rabbit
Purification: AP3B2 Antibody is affinity chromatography purified via peptide column.
Physical State: Liquid
CAS NO.: 1418741-86-2
Product: UNC1079
Buffer: AP3B2 Antibody is supplied in PBS containing 0.02% sodium azide.
Concentration: 1 mg/mL
Storage Conditions: AP3B2 antibody can be stored at 4˚C for three months and -20˚C, stable for up to one year. As with all antibodies care should be taken to avoid repeated freeze thaw cycles. Antibodies should not be exposed to prolonged high temperatures.
Clonality: Polyclonal
Conjugate: Unconjugated
Alternate Names: AP3B2 Antibody: NAPTB, AP-3 complex subunit beta-2, Adapter-related protein complex 3 subunit beta-2
Accession NO.: NP_001265440
Protein Ino: 34482047
Official Symbol: AP3B2
Geneid: 8120
Background: AP3B2 Antibody: The AP3 complex is a heterotetramer composed of two large adaptins (AP3D1, AP3B1 or AP3B2), a medium adaptin (AP3M1 or AP3M2) and a small adaptin (APS1 or AP3S2). The complex is associated with the Golgi region as well as more peripheral structures. It facilitates the budding of vesicles from the Golgi membrane and may be directly involved in trafficking to lysosomes. Unlike the homologous AP3B1, AP3B2-containing AP3 complexes are preferentially targeted to neuronal processes, and mice deficient in AP3B2 displayed compromised synaptic zinc stores.
PubMed ID:http://aac.asm.org/content/53/1/261.abstract
